Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2013-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijrobp.2013.08.049PMID 24210079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcomes following chemoradiotherapy for N3 head and neck squamous cell carcinoma without a planned neck dissection.

  2013cited by this paper
• Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.

  2013cited by this paper
• Patterns of failure and histopathologic outcome predictors following definitive radiotherapy and planned neck dissection with residual disease

  2012cited by this paper
• The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease.

  2012cited by this paper
• Mechanisms of cyst formation in metastatic lymph nodes of head and neck squamous cell carcinoma

  2012cited by this paper
• Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation.

  2012cited by this paper
• Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome

  2011cited by this paper
• Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis

  2011cited by this paper
• Human papillomavirus and survival of patients with oropharyngeal cancer.

  2010cited by this paper
• Point-of-care outcome assessment in the cancer clinic: audit of data quality.

  2010cited by this paper
• Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group.

  2010cited by this paper
• Planned neck dissection for patients with complete response to chemoradiotherapy: A concept approaching obsolescence

  2009cited by this paper
• N2‐N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders—Results of Trans Tasman Radiation Oncology Group Study 98.02

  2008cited by this paper
• Cystic lymph node metastasis in patients with head and neck cancer: An HPV‐associated phenomenon

  2008cited by this paper
• Pathology and FDG PET Correlation of Residual Lymph Nodes in Head and Neck Cancer After Radiation Treatment

  2007cited by this paper
• Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.

  2004cited by this paper
• Who merits a neck dissection after definitive chemoradiotherapy for N2–N3 squamous cell head and neck cancer?

  2003cited by this paper

• Prognostic Implications of HPV Cell-Free DNA Serial Testing During Follow-Up of p16 Positive Oropharyngeal Squamous Cell Carcinoma After Curative-Intent Treatment.

  2025cites this paper
• Management of Head and Neck Squamous Cell Carcinoma With N3 Nodal Disease.

  2025cites this paper
• Outcomes following IMRT alone in head and neck squamous cell carcinoma ordinarily managed with concurrent chemo-radiotherapy.

  2025cites this paper
• Advances and residual knowledge gaps in the neck management of head and neck squamous cell carcinoma patients with advanced nodal disease undergoing definitive (chemo)radiotherapy for their primary

  2024cites this paper
• Instant Oncology: PET-NECK.

  2024cites this paper
• Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline.

  2024cites this paper
• Posttreatment Head and Neck Cancer Imaging: Anatomic Considerations Based on Cancer Subsites.

  2024cites this paper
• Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review

  2023cites this paper
• [18F]FDG PET/CT in head and neck squamous cell carcinoma: a head-to-head between visual point-scales and the added value of multi-modality imaging

  2023cites this paper
• Management of head and neck carcinomas with synchronous or metachronous oligometastatic disease: Role of locoregional radiotherapy and metastasis-directed radiotherapy.

  2023cites this paper
• Individualization of treatment policy for patients with regional metastatic oropharyngeal carcinoma associated with human papillomavirus

  2022cites this paper
• Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.

  2022cites this paper
• Prospective Study of PET/MRI Tumor Response During Chemoradiotherapy for Patients With Low-risk and Intermediate-risk p16-positive Oropharynx Cancer

  2022influential citation
• Imaging of human papilloma virus associated oropharyngeal squamous cell carcinoma and its impact on diagnosis, prognostication, and response assessment

  2022cites this paper
• Response Evaluation Following Radiation Therapy With 18F-FDG PET/CT: Common Variants of Radiation-Induced Changes and Potential Pitfalls.

  2022cites this paper
• Accuracy of Response Assessment FDG PET-CT Post (Chemo)Radiotherapy in HPV Negative Oropharynx Squamous Cell Carcinoma

  2022cites this paper
• Persistent lymph nodes after curative chemoradiotherapy for head and neck cancer: imaging predictors of response for decision-making

  2022cites this paper
• Does Bulky Adenopathy in Human Papilloma Virus-Positive Oropharyngeal Squamous Cell Carcinoma Require a Planned Post-Treatment Neck Dissection for Occult Residual Disease?

  2022cites this paper
• Up‐front neck dissection followed by chemoradiotherapy for T1–T3 hypopharyngeal cancer with advanced nodal involvement

  2021cites this paper
• Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology.

  2021cites this paper
• Conventional Radiological Techniques and PET-CT in Treatment Response Evaluation in Post-Radiotherapy Setting

  2021cites this paper
• A cost‐utility analysis comparing CT surveillance, PET‐CT surveillance, and planned postradiation neck dissection for advanced nodal HPV‐positive oropharyngeal cancer

  2021influential citation
• MRI in head and neck cancer following chemoradiotherapy: what is the optimal delay to demonstrate maximal response?

  2021cites this paper
• Head and Neck Imaging Surveillance Strategy for HPV-positive Oropharyngeal Carcinoma Following Definitive (Chemo)Radiotherapy.

  2021cites this paper
• PET-CT for Staging and Detection of Recurrence of Head and Neck Cancer.

  2021cites this paper
• Comparison of diffusion-weighted MR imaging and 18F Fluorodeoxyglucose PET/CT in detection of residual or recurrent tumors and delineation of their local spread after (chemo) radiotherapy for head and neck squamous cell carcinoma.

  2020cites this paper
• 18F‐FDG PET/CT for response evaluation of regional lymph nodes in 97 head and neck squamous cell carcinoma patients: Differences in the predictive value of residual disease after radiotherapy and chemoradiotherapy

  2020cites this paper
• PET in the Diagnosis of Head and Neck Cancer

  2020cites this paper
• Comparative effectiveness of posttreatment imaging modalities for Medicare patients with advanced head and neck cancer

  2020cites this paper
• FDG PET Hybrid Imaging.

  2020cites this paper
• Positron Emission Tomography-Computed Tomography Surveillance after (Chemo)Radiotherapy in Advanced Head and Neck Squamous Cell Cancer: Beyond the PET-NECK Protocol.

  2020cites this paper
• Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter study

  2020cites this paper
• Evaluating of HPV–DNA ISH as an adjunct to p16 testing in oropharyngeal cancer

  2020cites this paper
• External validation of OroGrams as a predictive model for overall and progression-free survival in Scottish patients with oropharyngeal squamous cell carcinoma: a retrospective cohort study.

  2020cites this paper
• Overview of head and neck cancer management

  2020cites this paper
• Pre‐ and Post‐Radiotherapy Radiologic Nodal Features and Oropharyngeal Cancer Outcomes

  2020cites this paper
• Circulating tumor HPV DNA complements PET‐CT in guiding management after radiotherapy in HPV‐related squamous cell carcinoma of the head and neck

  2020influential citation
• The declining role of post-treatment neck dissection in human papillomavirus-associated oropharyngeal cancer.

  2020cites this paper
• Improving post-CRT neck assessment in patients with HPV-associated OPSCC (Review).

  2020cites this paper
• Diagnostic Imaging in Head and Neck Cancer

  2020cites this paper
• Head and Neck Cancers

  2019cites this paper
• Prognostic importance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma and its potential role in refining TNM-8 cN-classification.

  2019cites this paper
• Radiologic Extranodal Extension Portends Worse Outcome in cN+ TNM-8 Stage I Human Papillomavirus-Mediated Oropharyngeal Cancer.

  2019cites this paper
• Less is Enough: Outcome of Bimodality Definitive Concurrent Chemoradiation does not Differ from that of Trimodality Upfront Neck Dissection Followed by Adjuvant Treatment for >6 cm Bulky Lymph Node (N3) Head and Neck Cancer

  2019cites this paper
• Estudio imagenológico de linfonodos en oncología de cabeza y cuello

  2019cites this paper
• Differential Activation of ERK Signaling in HPV-Related Oropharyngeal Squamous Cell Carcinoma

  2019cites this paper
• Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.

  2019cites this paper
• FDG-PET/CT scan assessment of response 12 weeks post radical radiotherapy in oropharynx head and neck cancer: The impact of p16 status.

  2019cites this paper
• Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.

  2019cites this paper
• Emerging Opportunities for Digital PET/CT to Advance Locoregional Therapy in Head and Neck Cancer.

  2019cites this paper
• 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers.

  2019cites this paper
• Neck management in head and neck squamous cell carcinomas: where do we stand?

  2019cites this paper
• Finding/identifying primaries with neck disease (FIND) clinical trial protocol: a study integrating transoral robotic surgery, histopathological localisation and tailored deintensification of radiotherapy for unknown primary and small oropharyngeal head and neck squamous cell carcinoma

  2019cites this paper
• Survival outcomes for head and neck cancer patients with N3 cervical nodal metastases

  2019influential citation
• Tumor cell viability in salvage neck dissections: Poor prognosis predicted by high postradiation nodal SUVmax, p16‐negativity, and low nodal shrinkage

  2019cites this paper
• Outcome of bimodality definitive chemoradiation does not differ from that of trimodality upfront neck dissection followed by adjuvant treatment for >6 cm lymph node (N3) head and neck cancer

  2019cites this paper
• Optimal timing for salvage surgery after definitive radiotherapy in hypopharyngeal cancer

  2018cites this paper
• Viable tumor in salvage neck dissections in head and neck cancer: Relation with initial treatment, change of lymph node size and human papillomavirus.

  2018cites this paper
• FDG-PET/CT for treatment response assessment in head and neck squamous cell carcinoma: a systematic review and meta-analysis of diagnostic performance

  2018cites this paper
• Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC.

  2018cites this paper
• Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer.

  2018cites this paper
• Oncologic outcomes of extended neck dissections in human papillomavirus‐related oropharyngeal squamous cell carcinoma

  2018cites this paper
• The Current State of Biological and Clinical Implications of Human Papillomavirus-Related Oropharyngeal Cancer.

  2018cites this paper
• Chapter 11 Human Papillomavirus in Head and Neck Cancer

  2018cites this paper
• De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.

  2018cites this paper
• Surgery- vs Radiation-Based Therapy for p16+/HPV-Related Oropharyngeal Cancers

  2018cites this paper
• [Surgery or radiotherapy for oropharyngeal HPV-positive tumours?]

  2018cites this paper
• Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma

  2017cites this paper
• Outcomes of surgically treated human papillomavirus–related oropharyngeal squamous cell carcinoma with N3 disease

  2017cites this paper
• [Which recent results in Oncology and Hematology will have an impact on our practices? The point of vue of Bulletin du Cancer editorial board].

  2017cites this paper
• Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later.

  2017cites this paper
• Can Positron Emission Tomography Scans Post Chemoradiation in Head and Neck Squamous Cell Cancer Spare Patients From Undergoing Salvage Surgery

  2017cites this paper
• Post-treatment PET/CT and p16 status for predicting treatment outcomes in locally advanced head and neck cancer after definitive radiation

  2017cites this paper
• Optimizing Sequencing in Patients with NSCLC and Actionable Mutations | PER

  2017cites this paper
• Treatment of Viral-Associated HNC (OPC and NPC)

  2017cites this paper
• Radiotherapy response evaluation using FDG PET-CT-established and emerging applications.

  2017cites this paper
• Earlier and more specific detection of persistent neck disease with diffusion‐weighted MRI versus subsequent PET/CT after definitive chemoradiation for oropharyngeal squamous cell carcinoma

  2017cites this paper
• The risk of level IB nodal involvement in oropharynx cancer: Guidance for submandibular gland sparing irradiation.

  2017cites this paper
• Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.

  2017cites this paper
• Treatment de-intensification strategies for head and neck cancer.

  2016cites this paper
• Place du curage ganglionnaire avant radiothérapie exclusive dans la prise en charge des carcinomes épidermoïdes localement évolués des voies aérodigestives supérieures

  2016cites this paper
• Clinical Outcomes in Patients with Recurrent or Metastatic Human Papilloma Virus-positive Head and Neck Cancer.

  2016cites this paper
• [Value of neck dissection before definitive radiation therapy for locoregionally advanced squamous cell carcinoma of the head and neck].

  2016cites this paper
• Incidence and long‐term survival of patients with de novo head and neck carcinoma after liver transplantation

  2016cites this paper
• Improving Head and Neck Cancer Outcomes: Technology, Used Wisely.

  2016cites this paper
• 18F-FDG-PET/CT: Bildgestützte Überwachung als Alternative zur Neck Dissection bei fortgeschrittenen Kopf-Hals-Tumoren

  2016cites this paper
• PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.

  2016cites this paper
• PET-CT surveillance versus neck dissection in advanced head and neck cancer

  2016cites this paper
• University of Birmingham Management of advanced nodal disease in patients treated with primary chemoradiotherapy

  2016cites this paper
• HPV Associated Head and Neck Cancer

  2016cites this paper
• Human Papillomavirus in Head and Neck Cancer

  2016cites this paper
• Prognostic Value of p16 Status on the Development of a Complete Response in Involved Oropharynx Cancer Neck Nodes After Cisplatin-Based Chemoradiation: A Secondary Analysis of NRG Oncology RTOG 0129.

  2016cites this paper
• Cervical nodal metastases from head and neck squamous cell carcinoma: MRI criteria for treatment assessment

  2016cites this paper
• Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.

  2015cites this paper
• The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies

  2015cites this paper
• First Site of Failure Analysis Incompletely Addresses Issues of Late and Unexpected Metastases in p16-Positive Oropharyngeal Cancer.

  2015cites this paper
• Characterization of volume and shape modifications of PET-positive nodes during Tomotherapy for head and neck cancer as assessed by MVCTs.

  2015cites this paper
• Response evaluation of the neck in oropharyngeal cancer: Value of magnetic resonance imaging and influence of p16 in selecting patients for post-radiotherapy neck dissection

  2015cites this paper
• Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status

  2015influential citation
• DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck

  2015cites this paper